NCT02231437View on ClinicalTrials.gov

Post-marketing Surveillance of Berodual® Metered-dose Inhaler in the Treatment of Chronic Obstructive Respiratory Tract Disease

CompletedOBSERVATIONAL
Enrollment

3,488

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

November 30, 1999

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Berodual®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY